Lung Neoplasm Malignant Clinical Trials

ReadTheTrial indexes 2 studies for Lung Neoplasm Malignant. The most common development stage is Phase 2 (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Lung Neoplasm Malignant.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
100%

Trial Status Breakdown

Trials for Lung Neoplasm Malignant

KEYMAKER-U01 Substudy 01F: A Phase 1b/2 Umbrella Study With Rolling Arms of Investigational Agents for Previously Treated Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With KRAS G12C Mutations

NCT07286149 · RECRUITING · Phase 2

KEYMAKER-U01 Substudy 01E: A Phase 2 Umbrella Study With Rolling Arms of Investigational Agents With or Without Chemotherapy in Combination With Pembrolizumab in Treatment of Participants With Newly Diagnosed Resectable Stages II-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)

NCT06788912 · RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Lung Neoplasm Malignant?

There are 2 clinical trials listed for Lung Neoplasm Malignant. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Lung Neoplasm Malignant trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Lung Neoplasm Malignant trials in?

Current Lung Neoplasm Malignant trials are distributed across: Phase 2 (2).

Find More Trials